Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
Jonathan T. Sims(University of Kentucky), Rina Plattner(University of Kentucky)
Cited by 132
Related Papers
Activation of Abl Tyrosine Kinases Promotes Invasion of Aggressive Breast Cancer Cells
|Cancer Research|2006|199